Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerink’s Target Price Boost to $13
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
Certara, Inc. (NASDAQ:CERT) Given Average Recommendation of “Hold” by Analysts
Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat reports. Six ...
Nasdaq16d
Certara, Inc. Reports Preliminary Full-Year 2024 Revenue of $384.4 Million and Bookings of $445.3 Million
Certara reports 2024 revenue of $384.4 million, bookings of $445.3 million, and confirms adjusted EBITDA guidance of $120-$124 million. Certara, Inc. reported preliminary financial results for ...
Nasdaq9d
Certara Breaks Above 200-Day Moving Average - Bullish for CERT
In trading on Wednesday, shares of Certara Inc (Symbol: CERT) crossed above their 200 day moving average of $13.29, changing hands as high as $13.68 per share. Certara Inc shares are currently ...
Business Insider14d
Certara’s Solid FY24 Performance and Cautious Outlook Lead to Hold Rating Despite Increased Price Target
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Certara (CERT – Research Report), boosting the price target to $13.00. Discover outperforming stocks and invest smarter ...
William Blair Brokers Raise Earnings Estimates for Certara
William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...
Morgan Stanley Keeps Their Hold Rating on Certara (CERT)
In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Certara (CERT – Research Report), with a price ...